Weekly Recap | ASCENTAGE +9.01%, most brokers rate it buyWeekly Review·Nov 7, 2026 at 06:26 AM06855-2.74%
Weekly Recap | ASCENTAGE +2.08%, Lisaftoclax wins breakthrough designationWeekly Review·Oct 24, 2026 at 05:46 AM06855-2.74%
Weekly Recap | ASCENTAGE -0.47%, most brokers rate it buyWeekly Review·Oct 17, 2026 at 06:14 AM06855-2.74%
Weekly Recap | ASCENTAGE +0.64%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 05:45 AM06855-2.74%
Weekly Recap | ASCENTAGE this week, insider buying meets strong buy consensusWeekly Review·Oct 3, 2026 at 05:57 AM06855-2.74%
Weekly Recap | ASCENTAGE -8.83%, most brokers rate it buyWeekly Review·Sep 26, 2026 at 05:39 AM06855-2.74%
Weekly Recap | ASCENTAGE -7.8%, consensus target above spotWeekly Review·Sep 19, 2026 at 05:18 AM06855-2.74%
